Skip to main content

Table 2 Participant characteristics

From: Prehabilitation in high-risk patients scheduled for major abdominal cancer surgery: a feasibility study

  Overall (n=50)
Gender (male, n (%)) 26 (52%)
Age (years), median [IQR] 71 [63–77]
Age (years), range 44–84
Colinet Comorbidity Score, median [IQR] 10.5 [6.75–12.25]
ARISCAT, n (%)
 Intermediate risk 27 (54%)
 High risk 23 (46%)
At risk of malnutrition, n (%)a
 Yes 16 (40%)
 No 27 (63%)
Cancer type, n (%)
 Colorectal 32 (64%)
 Oesophageal 9 (18%)
 Sarcoma 6 (12%)
 Pancreatic 1 (2%)
 Prostate 1 (2%)
 Gastric 1 (2%)
Surgery type, n (%)
 Bowel resection 12 (24%)
 Oesophagectomy 9 (18%)
 Cytoreductive surgery with HIPEC 8 (16%)
 Pelvic exenteration 6 (12%)
 Ultra-low anterior resection 6 (12%)
 Sarcoma resection 3 (6%)
 Pancreatectomy 1 (2%)
 Prostatectomy 1 (2%)
 Gastrectomy 1 (2%)
 Debulking surgery 1 (2%)
 Reversal of Hartmans 1 (2%)
 Whipples operation 1 (2%)
CPET-derived variables
 AT (mL/kg/min), mean±SD 9.8±1.8
 VO2 Peak (mL/kg/min), mean±SD 14.0±2.9
 VO2 Peak/BSA (mLs/kg), mean±SD 578±121
Smoking status, n (%)
 Never smoked 13 (26%)
 Quit smoking >2 months 32 (64%)
 Current smoker 5 (10%)
Living situation, n (%)
 Living alone 9 (18%)
 Living with family 41 (82%)
Residing >30km from hospital, n (%) 34 (68%)
Reported currently not exercising, n (%) 40 (80%)
  1. Abbreviations: ARISCAT Assess Respiratory Risk in Surgical Patients in Catalonia, BSA body surface area, CPET cardiopulmonary exercise test, HIPEC hyperthermic intraperitoneal chemotherapy. an=43, 7 missing Malnutrition Screening Tool Results